M D Scarpati, G Vicidomini, M Santini. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antimetabolites, Antineoplastic/pharmacologyAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useBrain Neoplasms/secondaryCarcinoma, Small Cell/drug therapyCarcinoma, Small Cell/pathologyCyclophosphamide/administration & dosageDeoxycytidine/analogs & derivativesDeoxycytidine/pharmacologyDoxorubicin/administration & dosageDrug Resistance, NeoplasmHumansLung Neoplasms/drug therapyLung Neoplasms/pathologyMaleMiddle AgedPrognosisVincristine/administration & dosage
Substances： See more » Antimetabolites, AntineoplasticDeoxycytidineVincristineDoxorubicinCyclophosphamidegemcitabine
Year: 2001 PMID： 11679191 DOI： 10.1016/s0169-5002(01)00237-9
Source DB: PubMed Journal: Lung Cancer ISSN： 0169-5002 Impact factor: 5.705